Remember meForgot password?
    Log in with Twitter

article imageCompounding pharmacy recalls medicines

By Tim Sandle     Dec 28, 2013 in Health
Dallas - The U.S. Food and Drug Administration has alerted hospitals, health care professionals, and patients of a voluntary recall of all non-expired drug products produced and distributed for sterile use by a Dallas Compounding Pharmacy.
The pharmacy in question is Abrams Pharmacy in Dallas, Texas. The recalled products include injectable medications, intravenous (IV) injections, eye drops, pellet implants, nasal sprays, inhalation solutions, and eye ointments that were distributed between June 17, 2013 and Dec. 17, 2013.
The recall comes only days after the Royal Pharmacy announced a similar recall of its sterile medicines.
Contaminated sterile drugs put patients at risk of serious infection. Health care professionals who have received the affected products should stop using them and follow Abrams’ recall instructions.
The FDA is aware of one adverse event associated with mineral IV injection produced by Abrams’ lot number 11142013@74. A patient who received this product was admitted to a hospital in California and had blood cultures that tested positive for Stenotrophomonas maltophilia, a bacterium that can cause many types of infections. These include respiratory infections such as pneumonia, bloodstream infections and meningitis. In addition, Abrams identified a similar gram-negative bacterium in the same lot of mineral IV injection.
More about Recall, Pharmacy, Drugs, Medicines, Fda
More news from
Latest News
Top News